default author photo

Jian-Yong Li

The First Affiliated Hospital of Nanjing Medical University - Department of Hematology

Nanjing, 210029

China

  • The First Affiliated Hospital of Nanjing Medical University - Department of Hematology

SCHOLARLY PAPERS

6

DOWNLOADS

392

TOTAL CITATIONS

0

Scholarly Papers (6)

Actions:
Email selected abstracts
1.

Single-Cell RNA-Seq Reveals LGALS1 and LAG3 as Novel Drivers of Ibrutinib Resistance in Chronic Lymphocytic Leukemia

Number of pages: 34 Posted: 09 Sep 2021
Hui Jin, Bin Huang, Zijuan Wu, Huayuan Zhu, Hanning Tang, Jia-Zhu Wu, Danling Gu, Yun Cai, Luqiao Wang, Xueying Lu, Wei Xu, Kening Li, Qianghu Wang and Jian-Yong Li
Nanjing Medical University - Department of Hematology, Nanjing Medical University - Center for Global Health, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Center for Global Health, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Center for Global Health, Nanjing Medical University - Center for Global Health and The First Affiliated Hospital of Nanjing Medical University - Department of Hematology
Downloads 131 (554,631)

Abstract:

Loading...

Chronic lymphocytic leukemia, Ibrutinib resistance, Single-cell RNA sequencing, Galectin-1 inhibitor

2.

Penpulimab in Combination with Lenalidomide and R-GemOx Regimen (R2-GemOx-PD1i) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Multicentre, Single-Arm, Phase 2 Trial

Number of pages: 27 Posted: 01 May 2025
Jin-Hua Liang, Hua Yin, Wei-Ying Gu, Tong-Yao Xing, Qing-Shu Zeng, Kai-Xin Du, Luthuli Sibusiso, Jia-Zhu Wu, Yue Li, Fei Wang, Rui Gao, Jian-Yong Li, Hao-Rui Shen, Li Wang and Wei Xu
Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University, Nanjing Medical University, Anhui Medical University, Nanjing Medical University, Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University, Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology and The First Affiliated Hospital of Nanjing Medical University - Department of Hematology
Downloads 82 (790,029)

Abstract:

Loading...

DLBCL, penpulimab, lenalidomide, R-GemOx, efficacy, relapsed, refractory

3.

A Phase I Study of C-CAR088, a Novel Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myelomaa

Number of pages: 35 Posted: 16 Mar 2022
Xiaoyan Qu, Gang An, Weiwei Sui, Tingyu Wang, Xian Zhang, Junfang Yang, Yan Zhang, Lu Zhang, Dan Zhu, Jiaqi Huang, Shigui Zhu, Xin Yao, Jing Li, Chengxiao Zheng, Kevin Zhu, Yutiang Wei, Xiaoteng Lv, Liping Lan, Yihong Yao, Daobin Zhou, Peihua Lu, Lugui Qiu and Jian-Yong Li
Nanjing Medical University - Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Hebei Yanda Lu Daopei Hospital - Department of Hematology, Hebei Yanda Lu Daopei Hospital - Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Hematology, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, - Department of Hematology/Oncology, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Hematology, Hebei Yanda Lu Daopei Hospital - Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology and The First Affiliated Hospital of Nanjing Medical University - Department of Hematology
Downloads 75 (837,727)

Abstract:

Loading...

CAR T cell therapy, relapsed/refractory multiple myeloma

4.

Chidamide-BEAC Plus Autologous Stem Cell Transplantation in High-Risk Non-Hodgkin Lymphoma: A Phase II Clinical Trial

Number of pages: 28 Posted: 27 Jan 2023
Yi Xia, Li Wang, Kaiyang Ding, Jia-Zhu Wu, Hua Yin, Maogui Hu, Hao-Rui Shen, Jin-Hua Liang, Ruize Chen, Yue Li, Huayuan Zhu, Jian-Yong Li and Wei Xu
Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Anhui Provincial Hospital - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Anhui Provincial Hospital - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology and The First Affiliated Hospital of Nanjing Medical University - Department of Hematology
Downloads 64 (924,743)

Abstract:

Loading...

Chidamide, BEAC, autologous stem cell transplantation, high-risk, non-Hodgkin lymphoma

5.

Single-Cell Transcriptome Analysis Uncovers Heterogeneity and Key Regulators in Ibrutinib-Resistant Chronic Lymphocytic Leukemia

Number of pages: 45 Posted: 12 Nov 2021
Hui Jin, Bin Huang, Zijuan Wu, Huayuan Zhu, Hanning Tang, Jia-Zhu Wu, Luqiao Wang, Xueying Lu, Yun Cai, Danling Gu, Wei Xu, Kening Li, Qianghu Wang and Jian-Yong Li
The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Center for Global Health, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Center for Global Health, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Center for Global Health, Nanjing Medical University - Center for Global Health and The First Affiliated Hospital of Nanjing Medical University - Department of Hematology
Downloads 23 (1,411,822)

Abstract:

Loading...

chronic lymphocytic leukemia, Ibrutinib resistance, single-cell RNA sequencing, LGALS1, LAG3

6.

Measurable Residual Disease Before the Second Consolidation Guides Monitoring in Acute Promyelocytic Leukemia Treated with Retinoic Acid and Arsenic Trioxide

Number of pages: 27 Posted: 09 Jun 2025
Li Chen, Hong-Ming Zhu, Fangyi Dong, Yan Li, Qifa Liu, Yu Hu, Yicheng Zhang, Jie Jin, JianDa Hu, Ting Liu, Depei Wu, Jieping Chen, Yongrong Lai, Jianxiang Wang, Juan Li, Jian-Yong Li, Xin Du, Xin Wang, Minzheng Yang, Jinsong Yan, Guifang Ouyang, Li Liu, Ming Hou, Xiao-Jun Huang, Yuting Huang, Xuefei Ma, Wen Jin, Li Jian, Junmin Li, Kankan Wang and Sai-Juan Chen
affiliation not provided to SSRN, Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics, affiliation not provided to SSRN, affiliation not provided to SSRN, Southern Medical University - Department of Hematology, Huazhong University of Science and Technology - Institute of Hematology, Huazhong University of Science and Technology, Zhejiang University - Department of Hematology, Fujian Medical University - Fujian Provincial Key Laboratory on Hematology, Sichuan University - Hematology Research Laboratory, Soochow University - National Clinical Research Center for Hematologic Diseases, Government of the People's Republic of China - Center for Hematology, Guangxi Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, affiliation not provided to SSRN, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Dalian University of Technology - The Second Affiliated Hospital of Dalian Medical University, affiliation not provided to SSRN, affiliation not provided to SSRN, Shandong University - Department of Hematology, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics
Downloads 17 (1,481,165)

Abstract:

Loading...

Acute promyelocytic leukemia, PML::RARA fusion gene, measurable residual disease, the second consolidation therapy, relapse